Daily aspirin found to have no benefit for healthy seniors


Make text smaller Make text larger



Photos





Low-dose aspirin therapy in older healthy adults without previous cardiovascular events did not prolong healthy independent living, according to an international study.

“This is a critically important study because many older adults who never had a heart attack or a stroke are taking aspirin,” says Dr. Elena Volpi, principal investigator of the University of Texas Medical Branch, Sealy Center on Aging, one of 34 clinical sites in the United States taking part in the Aspirin in Reducing Events in the Elderly trial. “In this study aspirin did not protect from developing dementia or physical disability, but it increased the risk of death.”

More than 19,000 people 65 and older in the United States and Australia participated in the study, which began in 2010 to see if aspirin would increase survival free of persistent physical disability or dementia.

Upon enrolling, participants could not have dementia or a physical disability and had to be free of medical conditions requiring aspirin use. Individuals with stable chronic diseases, such as high blood pressure or diabetes, were included in the study. Participants were followed an average of 4.7 years to determine outcomes.

Researchers found that the rates for major cardiovascular events, including coronary heart disease, nonfatal heart attacks, and fatal and nonfatal ischemic stroke were similar for those taking aspirin when compared to those taking a placebo.

The increased risk of death found in participants taking aspirin appeared to be mostly due to cancer deaths. However, the researchers urge caution saying those findings indicate a need for more long-term studies.

Researchers also examined the risk of major bleeding, a recognized side effect of aspirin use, and found a significant increase in bleeding risk with aspirin. This finding was consistent with results from many other aspirin studies.

The takeaway message is that for healthy people over 70, daily use of low-dose aspirin does not appear to extend a healthy life span.

Leaders of the ASPREE team include John McNeil of Monash University, Australia and Anne Murray of the Berman Center for Outcomes and Clinical Research at Hennepin Healthcare in Minneapolis.

The study, published in three papers in The New England Journal of Medicine, received support from the National Institute on Aging and the National Cancer Institute.

Source: University of Texas Medical Branch at Galveston: utmb.edu



Make text smaller Make text larger

Comments

Pool Rules



MUST READ NEWS

First Shop Local Sweepstakes winner announced
The first week of our shop local sweepstakes came to a close with a lucky winner, Nicole Karchner! Nicole submitted her receipt from Bliss Boutique in Goshen and won...
Read more »
Image

Santa Koz is coming to town
Multi-Grammy nominee and saxophonist extraordinaire Dave Koz returns to Mayo Performing Arts Center for a spirited holiday...
Read more »
Image

Celtic Woman to celebrate holidays in Morristown
Popular Irish recording artist Celtic Woman brings its holiday show, The Best of Christmas, to Mayo Performing Arts Center on...
Read more »
Image

Labor Dept. announces internship opportunities
The New Jersey Department of Labor and Workforce Development (NJDOL) announced a Notice of Grant Opportunity on Thursday of up to $2,000,000 to support career development through...
Read more »

VIDEOS



Subscribe to our mailing list

* indicates required
Community Newspapers



MOST READ

Obituaries
Daniel William Abbott
  • Nov 9, 2018
Honor Rolls/Dean's List
HONOR ROLL: Franklin Borough School
  • Nov 9, 2018

MOST COMMENTED



Weather in Lafayette, NJ